{"transactions":[{"id":3519810,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:18:50.000Z","date":"2026-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4398,"price":3.23,"value":14205.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026."}],"balance_after":305964,"source":{"system":"sec-edgar","filing":"0001914879-26-000004","document":"wk-form4_1788898728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000191487926000004/wk-form4_1788898728.xml","form_type":"4"}},{"id":842663,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:54.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5995,"price":4.66,"value":27936.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":310362,"source":{"system":"sec-edgar","filing":"0001914879-26-000002","document":"wk-form4_1773695152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487926000002/wk-form4_1773695152.xml","form_type":"4"}},{"id":842662,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:54.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":195876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":316357,"source":{"system":"sec-edgar","filing":"0001914879-26-000002","document":"wk-form4_1773695152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487926000002/wk-form4_1773695152.xml","form_type":"4"}},{"id":1048700,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-04T20:14:17.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4435,"price":6.8,"value":30158.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 3, 2025."}],"balance_after":120481,"source":{"system":"sec-edgar","filing":"0001914879-25-000004","document":"wk-form4_1757016855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487925000004/wk-form4_1757016855.xml","form_type":"4"}},{"id":1204838,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:46.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":63145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":124916,"source":{"system":"sec-edgar","filing":"0001628280-25-013147","document":"wk-form4_1742242778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013147/wk-form4_1742242778.xml","form_type":"4"}},{"id":1416750,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-09-04T23:51:38.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":61771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":61771,"source":{"system":"sec-edgar","filing":"0001914879-24-000007","document":"wk-form4_1725487665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487924000007/wk-form4_1725487665.xml","form_type":"4"}},{"id":1455426,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2024-07-12T16:33:12.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Amended and Restated Stock Incentive Plan. These restricted stock units vest in one installment on the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":186382,"source":{"system":"sec-edgar","filing":"0001367644-24-000126","document":"wk-form4_1720816385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000126/wk-form4_1720816385.xml","form_type":"4"}},{"id":1483753,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2024-06-11T16:10:56.000Z","date":"2024-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2376,"price":6.19,"value":14707.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":171382,"source":{"system":"sec-edgar","filing":"0001367644-24-000108","document":"wk-form4_1718136649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000108/wk-form4_1718136649.xml","form_type":"4"}},{"id":1575003,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2024-03-15T17:16:03.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":223169,"derivative":{"exercise_price":2.33,"expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001367644-24-000042","document":"wk-form4_1710537351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000042/wk-form4_1710537351.xml","form_type":"4"}},{"id":1603646,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-04T18:42:33.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":3.39,"value":2383.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":173758,"source":{"system":"sec-edgar","filing":"0001367644-24-000019","document":"wk-form4_1709595745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000019/wk-form4_1709595745.xml","form_type":"4"}},{"id":1603645,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-04T18:42:33.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":4103,"price":3.23,"value":13252.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":174461,"source":{"system":"sec-edgar","filing":"0001367644-24-000019","document":"wk-form4_1709595745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000019/wk-form4_1709595745.xml","form_type":"4"}},{"id":1616294,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2024-02-27T20:28:41.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":229,"price":2.74,"value":627.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":178564,"source":{"system":"sec-edgar","filing":"0001367644-24-000010","document":"wk-form4_1709083709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764424000010/wk-form4_1709083709.xml","form_type":"4"}},{"id":1742539,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-11-14T19:28:25.000Z","date":"2023-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":413,"price":2,"value":826.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":178793,"source":{"system":"sec-edgar","filing":"0001367644-23-000191","document":"wk-form4_1700008089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000191/wk-form4_1700008089.xml","form_type":"4"}},{"id":1857473,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-06-13T21:22:21.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":98169,"derivative":{"exercise_price":8.39,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":49231},"source":{"system":"sec-edgar","filing":"0001367644-23-000123","document":"wk-form4_1686705732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000123/wk-form4_1686705732.xml","form_type":"4"}},{"id":1857472,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-06-13T21:22:21.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":179206,"source":{"system":"sec-edgar","filing":"0001367644-23-000123","document":"wk-form4_1686705732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000123/wk-form4_1686705732.xml","form_type":"4"}},{"id":1857471,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-06-13T21:22:21.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":24616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":129975,"source":{"system":"sec-edgar","filing":"0001367644-23-000123","document":"wk-form4_1686705732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000123/wk-form4_1686705732.xml","form_type":"4"}},{"id":1969524,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-06T19:35:58.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":48938,"derivative":{"exercise_price":12.06,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":12308},"source":{"system":"sec-edgar","filing":"0001367644-23-000067","document":"wf-form4_167814934737010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000067/wf-form4_167814934737010.xml","form_type":"4"}},{"id":1969523,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-06T19:35:58.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":105359,"source":{"system":"sec-edgar","filing":"0001367644-23-000067","document":"wf-form4_167814934737010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000067/wf-form4_167814934737010.xml","form_type":"4"}},{"id":1969522,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-06T19:35:58.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":6154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":93051,"source":{"system":"sec-edgar","filing":"0001367644-23-000067","document":"wf-form4_167814934737010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000067/wf-form4_167814934737010.xml","form_type":"4"}},{"id":1980101,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-02T14:43:47.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":1005,"price":12.38,"value":12441.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":86897,"source":{"system":"sec-edgar","filing":"0001367644-23-000060","document":"wf-form4_167778621301638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000060/wf-form4_167778621301638.xml","form_type":"4"}},{"id":1990676,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-27T20:22:43.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":258,"price":13.71,"value":3537.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":87902,"source":{"system":"sec-edgar","filing":"0001367644-23-000034","document":"wf-form4_167754734539183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000034/wf-form4_167754734539183.xml","form_type":"4"}},{"id":1990675,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-27T20:22:43.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":231,"price":14.3,"value":3303.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":88160,"source":{"system":"sec-edgar","filing":"0001367644-23-000034","document":"wf-form4_167754734539183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764423000034/wf-form4_167754734539183.xml","form_type":"4"}},{"id":2088257,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2022-12-13T17:18:13.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":42135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the day prior to the second anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":88391,"source":{"system":"sec-edgar","filing":"0001367644-22-000155","document":"wf-form4_167096987928470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000155/wf-form4_167096987928470.xml","form_type":"4"}},{"id":2088256,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2022-12-13T17:18:13.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":14045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":46256,"source":{"system":"sec-edgar","filing":"0001367644-22-000155","document":"wf-form4_167096987928470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000155/wf-form4_167096987928470.xml","form_type":"4"}},{"id":2116467,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2022-11-15T16:13:50.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":416,"price":15,"value":6240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022."}],"balance_after":32211,"source":{"system":"sec-edgar","filing":"0001367644-22-000146","document":"wf-form4_166854681352678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000146/wf-form4_166854681352678.xml","form_type":"4"}},{"id":2355467,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-03-03T18:28:07.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":26584,"price":41.38,"value":1100045.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":26584,"derivative":{"exercise_price":41.38,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":26584},"source":{"system":"sec-edgar","filing":"0001367644-22-000048","document":"wf-form4_164635006141702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000048/wf-form4_164635006141702.xml","form_type":"4"}},{"id":2355466,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-03T18:28:07.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":17794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (8,713 shares) or on the day prior to the second anniversary date of the grant (9,063 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":32627,"source":{"system":"sec-edgar","filing":"0001367644-22-000048","document":"wf-form4_164635006141702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000048/wf-form4_164635006141702.xml","form_type":"4"}},{"id":2355465,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Ext Aff, GC, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-03T18:28:07.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":7583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":14833,"source":{"system":"sec-edgar","filing":"0001367644-22-000048","document":"wf-form4_164635006141702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000136764422000048/wf-form4_164635006141702.xml","form_type":"4"}}]}